Drug-eluting stents enter periphery in U.S.

Article

While drug-eluting stents have proved successful in repairing coronary arteries, the periphery has been more challenging. The first FDA-approved clinical trial of a drug-coated stent for a peripheral artery began in October.

The DESTINY Trial will examine the effectiveness of the Zilver PTX drug-eluting stent in the above-the-knee femoropopliteal artery. The stent, made by Cook, is self-expanding and coated with the antitumor agent paclitaxel.

The trial will initially be conducted at 10 facilities and will enroll 60 patients. The Zilver PTX stent is 8 cm long, allowing for treatment of lesions up to 7 cm. A maximum of one drug-eluting stent will be implanted per patient. The trial will allow for another Zilver bare metal stent to be used in conjunction with the Zilver PTX if there is a dissection.

Results reported earlier this year from the first phase of the SIROCCO Trial conducted in Europe showed promise for the Cordis Smart sirolimus-eluting stent in the periphery. The stent was 8 cm long and 1 to 2 mm larger than the vessel diameter (6 to 7 mm). A maximum of three stents per patient were implanted. Investigators also determined that a slow-eluting rate is better than a faster one.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.